source name	characteristics[organism]	characteristics[organism part]	characteristics[cell type]	characteristics[ancestry category]	characteristics[age]	characteristics[sex]	characteristics[individual]	characteristics[developmental stage]	characteristics[disease]	characteristics[depletion]	characteristics[biological replicate]	assay name	Technology type	comment[data file]	comment[file uri]	comment[fraction identifier]	comment[proteomics data acquisition method]	comment[label]	comment[technical replicate]	comment[cleavage agent details]	comment[instrument]	comment[separation]	comment[modification parameters]	comment[modification parameters]	comment[dissociation method]	comment[collision energy]	comment[precursor mass tolerance]	comment[fragment mass tolerance]	factor value[organism part]
PXD029437-Sample-1	Homo sapiens	blood plasma	not applicable	not applicable	not available	not available	1	not applicable	covid-19	no depletion	1	run 1	proteomic profiling by mass spectrometry	15001181972.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/15001181972.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
PXD029437-Sample-2	Homo sapiens	blood plasma	not applicable	not applicable	not available	not available	2	not applicable	covid-19	no depletion	2	run 2	proteomic profiling by mass spectrometry	15001182033.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/15001182033.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
PXD029437-Sample-3	Homo sapiens	blood plasma	not applicable	not applicable	not available	not available	3	not applicable	covid-19	no depletion	3	run 3	proteomic profiling by mass spectrometry	15001182081.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/15001182081.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
PXD029437-Sample-4	Homo sapiens	blood plasma	not applicable	not applicable	not available	not available	4	not applicable	covid-19	no depletion	4	run 4	proteomic profiling by mass spectrometry	15001182147.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/15001182147.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
PXD029437-Sample-5	Homo sapiens	blood plasma	not applicable	not applicable	not available	not available	5	not applicable	covid-19	no depletion	5	run 5	proteomic profiling by mass spectrometry	15001237815.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/15001237815.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
PXD029437-Sample-6	Homo sapiens	blood plasma	not applicable	not applicable	not available	not available	6	not applicable	covid-19	no depletion	6	run 6	proteomic profiling by mass spectrometry	15001237871.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/15001237871.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
PXD029437-Sample-7	Homo sapiens	blood plasma	not applicable	not applicable	not available	not available	7	not applicable	covid-19	no depletion	7	run 7	proteomic profiling by mass spectrometry	15001237881.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/15001237881.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
PXD029437-Sample-8	Homo sapiens	blood plasma	not applicable	not applicable	not available	not available	8	not applicable	covid-19	no depletion	8	run 8	proteomic profiling by mass spectrometry	15001237912.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/15001237912.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
PXD029437-Sample-9	Homo sapiens	blood plasma	not applicable	not applicable	not available	not available	9	not applicable	covid-19	no depletion	9	run 9	proteomic profiling by mass spectrometry	15001237932.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/15001237932.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
PXD029437-Sample-10	Homo sapiens	blood plasma	not applicable	not applicable	not available	not available	10	not applicable	covid-19	no depletion	10	run 10	proteomic profiling by mass spectrometry	15001237942.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/15001237942.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
PXD029437-Sample-11	Homo sapiens	blood plasma	not applicable	not applicable	not available	not available	11	not applicable	covid-19	no depletion	11	run 11	proteomic profiling by mass spectrometry	15001237965.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/15001237965.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
PXD029437-Sample-12	Homo sapiens	blood plasma	not applicable	not applicable	not available	not available	12	not applicable	covid-19	no depletion	12	run 12	proteomic profiling by mass spectrometry	15001237970.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/15001237970.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
PXD029437-Sample-13	Homo sapiens	blood plasma	not applicable	not applicable	not available	not available	13	not applicable	covid-19	no depletion	13	run 13	proteomic profiling by mass spectrometry	15001238002.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/15001238002.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
PXD029437-Sample-14	Homo sapiens	blood plasma	not applicable	not applicable	not available	not available	14	not applicable	covid-19	no depletion	14	run 14	proteomic profiling by mass spectrometry	15001238074.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/15001238074.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
PXD029437-Sample-15	Homo sapiens	blood plasma	not applicable	not applicable	not available	not available	15	not applicable	covid-19	no depletion	15	run 15	proteomic profiling by mass spectrometry	15001238091.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/15001238091.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
PXD029437-Sample-16	Homo sapiens	blood plasma	not applicable	not applicable	not available	not available	16	not applicable	covid-19	no depletion	16	run 16	proteomic profiling by mass spectrometry	15001238101.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/15001238101.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
PXD029437-Sample-17	Homo sapiens	blood plasma	not applicable	not applicable	not available	not available	17	not applicable	covid-19	no depletion	17	run 17	proteomic profiling by mass spectrometry	15001238105.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/15001238105.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
PXD029437-Sample-18	Homo sapiens	blood plasma	not applicable	not applicable	not available	not available	18	not applicable	covid-19	no depletion	18	run 18	proteomic profiling by mass spectrometry	15001238112.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/15001238112.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
PXD029437-Sample-19	Homo sapiens	blood plasma	not applicable	not applicable	not available	not available	19	not applicable	covid-19	no depletion	19	run 19	proteomic profiling by mass spectrometry	15001238117.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/15001238117.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
PXD029437-Sample-20	Homo sapiens	blood plasma	not applicable	not applicable	not available	not available	20	not applicable	covid-19	no depletion	20	run 20	proteomic profiling by mass spectrometry	15001238123.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/15001238123.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
PXD029437-Sample-21	Homo sapiens	blood plasma	not applicable	not applicable	not available	not available	21	not applicable	covid-19	no depletion	21	run 21	proteomic profiling by mass spectrometry	15001238145.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/15001238145.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
PXD029437-Sample-22	Homo sapiens	blood plasma	not applicable	not applicable	not available	not available	22	not applicable	covid-19	no depletion	22	run 22	proteomic profiling by mass spectrometry	15001238153.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/15001238153.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
PXD029437-Sample-23	Homo sapiens	blood plasma	not applicable	not applicable	not available	not available	23	not applicable	covid-19	no depletion	23	run 23	proteomic profiling by mass spectrometry	15001238158.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/15001238158.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
PXD029437-Sample-24	Homo sapiens	blood plasma	not applicable	not applicable	not available	not available	24	not applicable	covid-19	no depletion	24	run 24	proteomic profiling by mass spectrometry	15001238160.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/15001238160.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
PXD029437-Sample-25	Homo sapiens	blood plasma	not applicable	not applicable	not available	not available	25	not applicable	covid-19	no depletion	25	run 25	proteomic profiling by mass spectrometry	15001238165.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/15001238165.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
PXD029437-Sample-26	Homo sapiens	blood plasma	not applicable	not applicable	not available	not available	26	not applicable	covid-19	no depletion	26	run 26	proteomic profiling by mass spectrometry	15001238182.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/15001238182.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
PXD029437-Sample-27	Homo sapiens	blood plasma	not applicable	not applicable	not available	not available	27	not applicable	covid-19	no depletion	27	run 27	proteomic profiling by mass spectrometry	15001238184.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/15001238184.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
PXD029437-Sample-28	Homo sapiens	blood plasma	not applicable	not applicable	not available	not available	28	not applicable	covid-19	no depletion	28	run 28	proteomic profiling by mass spectrometry	15001238201.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/15001238201.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
PXD029437-Sample-29	Homo sapiens	blood plasma	not applicable	not applicable	not available	not available	29	not applicable	covid-19	no depletion	29	run 29	proteomic profiling by mass spectrometry	15001238202.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/15001238202.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
PXD029437-Sample-30	Homo sapiens	blood plasma	not applicable	not applicable	not available	not available	30	not applicable	covid-19	no depletion	30	run 30	proteomic profiling by mass spectrometry	15001238211.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/15001238211.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
PXD029437-Sample-31	Homo sapiens	blood plasma	not applicable	not applicable	not available	not available	31	not applicable	covid-19	no depletion	31	run 31	proteomic profiling by mass spectrometry	15001238220.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/15001238220.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
PXD029437-Sample-32	Homo sapiens	blood plasma	not applicable	not applicable	not available	not available	32	not applicable	covid-19	no depletion	32	run 32	proteomic profiling by mass spectrometry	15001238222.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/15001238222.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
PXD029437-Sample-33	Homo sapiens	blood plasma	not applicable	not applicable	not available	not available	33	not applicable	covid-19	no depletion	33	run 33	proteomic profiling by mass spectrometry	15001238225.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/15001238225.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
PXD029437-Sample-34	Homo sapiens	blood plasma	not applicable	not applicable	not available	not available	34	not applicable	covid-19	no depletion	34	run 34	proteomic profiling by mass spectrometry	15001238232.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/15001238232.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
PXD029437-Sample-35	Homo sapiens	blood plasma	not applicable	not applicable	not available	not available	35	not applicable	covid-19	no depletion	35	run 35	proteomic profiling by mass spectrometry	15001238252.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/15001238252.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
PXD029437-Sample-36	Homo sapiens	blood plasma	not applicable	not applicable	not available	not available	36	not applicable	covid-19	no depletion	36	run 36	proteomic profiling by mass spectrometry	15001238257.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/15001238257.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
PXD029437-Sample-37	Homo sapiens	blood plasma	not applicable	not applicable	not available	not available	37	not applicable	covid-19	no depletion	37	run 37	proteomic profiling by mass spectrometry	15001238260.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/15001238260.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
PXD029437-Sample-38	Homo sapiens	blood plasma	not applicable	not applicable	not available	not available	38	not applicable	covid-19	no depletion	38	run 38	proteomic profiling by mass spectrometry	15001238262.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/15001238262.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
PXD029437-Sample-39	Homo sapiens	blood plasma	not applicable	not applicable	not available	not available	39	not applicable	covid-19	no depletion	39	run 39	proteomic profiling by mass spectrometry	15001238265.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/15001238265.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
PXD029437-Sample-40	Homo sapiens	blood plasma	not applicable	not applicable	not available	not available	40	not applicable	covid-19	no depletion	40	run 40	proteomic profiling by mass spectrometry	15001238277.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/15001238277.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
PXD029437-Sample-41	Homo sapiens	blood plasma	not applicable	not applicable	not available	not available	41	not applicable	covid-19	no depletion	41	run 41	proteomic profiling by mass spectrometry	15001238279.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/15001238279.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
PXD029437-Sample-42	Homo sapiens	blood plasma	not applicable	not applicable	not available	not available	42	not applicable	covid-19	no depletion	42	run 42	proteomic profiling by mass spectrometry	15001238282.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/15001238282.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
PXD029437-Sample-43	Homo sapiens	blood plasma	not applicable	not applicable	not available	not available	43	not applicable	covid-19	no depletion	43	run 43	proteomic profiling by mass spectrometry	15001238285.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/15001238285.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
PXD029437-Sample-44	Homo sapiens	blood plasma	not applicable	not applicable	not available	not available	44	not applicable	covid-19	no depletion	44	run 44	proteomic profiling by mass spectrometry	15001238286.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/15001238286.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
PXD029437-Sample-45	Homo sapiens	blood plasma	not applicable	not applicable	not available	not available	45	not applicable	covid-19	no depletion	45	run 45	proteomic profiling by mass spectrometry	15001238289.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/15001238289.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
PXD029437-Sample-46	Homo sapiens	blood plasma	not applicable	not applicable	not available	not available	46	not applicable	covid-19	no depletion	46	run 46	proteomic profiling by mass spectrometry	15001238290.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/15001238290.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
PXD029437-Sample-47	Homo sapiens	blood plasma	not applicable	not applicable	not available	not available	47	not applicable	covid-19	no depletion	47	run 47	proteomic profiling by mass spectrometry	15001238293.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/15001238293.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
PXD029437-Sample-48	Homo sapiens	blood plasma	not applicable	not applicable	not available	not available	48	not applicable	covid-19	no depletion	48	run 48	proteomic profiling by mass spectrometry	15001238299.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/15001238299.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
PXD029437-Sample-49	Homo sapiens	blood plasma	not applicable	not applicable	not available	not available	49	not applicable	covid-19	no depletion	49	run 49	proteomic profiling by mass spectrometry	15001238305.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/15001238305.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
PXD029437-Sample-50	Homo sapiens	blood plasma	not applicable	not applicable	not available	not available	50	not applicable	covid-19	no depletion	50	run 50	proteomic profiling by mass spectrometry	15001238367.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/15001238367.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
PXD029437-Sample-51	Homo sapiens	blood plasma	not applicable	not applicable	not available	not available	51	not applicable	covid-19	no depletion	51	run 51	proteomic profiling by mass spectrometry	15001238370.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/15001238370.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
PXD029437-Sample-52	Homo sapiens	blood plasma	not applicable	not applicable	not available	not available	52	not applicable	covid-19	no depletion	52	run 52	proteomic profiling by mass spectrometry	15001238387.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/15001238387.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
PXD029437-Sample-53	Homo sapiens	blood plasma	not applicable	not applicable	not available	not available	53	not applicable	covid-19	no depletion	53	run 53	proteomic profiling by mass spectrometry	15001238424.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/15001238424.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
PXD029437-Sample-54	Homo sapiens	blood plasma	not applicable	not applicable	not available	not available	54	not applicable	covid-19	no depletion	54	run 54	proteomic profiling by mass spectrometry	15001336415.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/15001336415.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
PXD029437-Sample-55	Homo sapiens	blood plasma	not applicable	not applicable	not available	not available	55	not applicable	covid-19	no depletion	55	run 55	proteomic profiling by mass spectrometry	15001336468.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/15001336468.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
PXD029437-Sample-56	Homo sapiens	blood plasma	not applicable	not applicable	not available	not available	56	not applicable	covid-19	no depletion	56	run 56	proteomic profiling by mass spectrometry	15001336476.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/15001336476.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
PXD029437-Sample-57	Homo sapiens	blood plasma	not applicable	not applicable	not available	not available	57	not applicable	covid-19	no depletion	57	run 57	proteomic profiling by mass spectrometry	15001336487.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/15001336487.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
PXD029437-Sample-58	Homo sapiens	blood plasma	not applicable	not applicable	not available	not available	58	not applicable	covid-19	no depletion	58	run 58	proteomic profiling by mass spectrometry	15001336488.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/15001336488.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
PXD029437-Sample-59	Homo sapiens	blood plasma	not applicable	not applicable	not available	not available	59	not applicable	covid-19	no depletion	59	run 59	proteomic profiling by mass spectrometry	15001336493.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/15001336493.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
PXD029437-Sample-60	Homo sapiens	blood plasma	not applicable	not applicable	not available	not available	60	not applicable	covid-19	no depletion	60	run 60	proteomic profiling by mass spectrometry	15001336511.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/15001336511.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
PXD029437-Sample-61	Homo sapiens	blood plasma	not applicable	not applicable	not available	not available	61	not applicable	covid-19	no depletion	61	run 61	proteomic profiling by mass spectrometry	15001336514.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/15001336514.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
PXD029437-Sample-62	Homo sapiens	blood plasma	not applicable	not applicable	not available	not available	62	not applicable	covid-19	no depletion	62	run 62	proteomic profiling by mass spectrometry	15001336515.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/15001336515.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
PXD029437-Sample-63	Homo sapiens	blood plasma	not applicable	not applicable	not available	not available	63	not applicable	covid-19	no depletion	63	run 63	proteomic profiling by mass spectrometry	15001336517.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/15001336517.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
PXD029437-Sample-64	Homo sapiens	blood plasma	not applicable	not applicable	not available	not available	64	not applicable	covid-19	no depletion	64	run 64	proteomic profiling by mass spectrometry	15001336534.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/15001336534.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
PXD029437-Sample-65	Homo sapiens	blood plasma	not applicable	not applicable	not available	not available	65	not applicable	covid-19	no depletion	65	run 65	proteomic profiling by mass spectrometry	15001336536.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/15001336536.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
PXD029437-Sample-66	Homo sapiens	blood plasma	not applicable	not applicable	not available	not available	66	not applicable	covid-19	no depletion	66	run 66	proteomic profiling by mass spectrometry	15001336542.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/15001336542.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
PXD029437-Sample-67	Homo sapiens	blood plasma	not applicable	not applicable	not available	not available	67	not applicable	covid-19	no depletion	67	run 67	proteomic profiling by mass spectrometry	15001336544.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/15001336544.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
PXD029437-Sample-68	Homo sapiens	blood plasma	not applicable	not applicable	not available	not available	68	not applicable	covid-19	no depletion	68	run 68	proteomic profiling by mass spectrometry	15001336546.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/15001336546.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
PXD029437-Sample-69	Homo sapiens	blood plasma	not applicable	not applicable	not available	not available	69	not applicable	covid-19	no depletion	69	run 69	proteomic profiling by mass spectrometry	15001336547.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/15001336547.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
PXD029437-Sample-70	Homo sapiens	blood plasma	not applicable	not applicable	not available	not available	70	not applicable	covid-19	no depletion	70	run 70	proteomic profiling by mass spectrometry	15001336569.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/15001336569.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
PXD029437-Sample-71	Homo sapiens	blood plasma	not applicable	not applicable	not available	not available	71	not applicable	covid-19	no depletion	71	run 71	proteomic profiling by mass spectrometry	15001336618.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/15001336618.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
PXD029437-Sample-72	Homo sapiens	blood plasma	not applicable	not applicable	not available	not available	72	not applicable	covid-19	no depletion	72	run 72	proteomic profiling by mass spectrometry	15001336624.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/15001336624.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
PXD029437-Sample-73	Homo sapiens	blood plasma	not applicable	not applicable	not available	not available	73	not applicable	covid-19	no depletion	73	run 73	proteomic profiling by mass spectrometry	15001336626.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/15001336626.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
PXD029437-Sample-74	Homo sapiens	blood plasma	not applicable	not applicable	not available	not available	74	not applicable	covid-19	no depletion	74	run 74	proteomic profiling by mass spectrometry	15001336656.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/15001336656.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
PXD029437-Sample-75	Homo sapiens	blood plasma	not applicable	not applicable	not available	not available	75	not applicable	covid-19	no depletion	75	run 75	proteomic profiling by mass spectrometry	15001336657.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/15001336657.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
PXD029437-Sample-76	Homo sapiens	blood plasma	not applicable	not applicable	not available	not available	76	not applicable	covid-19	no depletion	76	run 76	proteomic profiling by mass spectrometry	15001336664.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/15001336664.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
PXD029437-Sample-77	Homo sapiens	blood plasma	not applicable	not applicable	not available	not available	77	not applicable	covid-19	no depletion	77	run 77	proteomic profiling by mass spectrometry	15001336668.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/15001336668.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
PXD029437-Sample-78	Homo sapiens	blood plasma	not applicable	not applicable	not available	not available	78	not applicable	covid-19	no depletion	78	run 78	proteomic profiling by mass spectrometry	15001336698.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/15001336698.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
PXD029437-Sample-79	Homo sapiens	blood plasma	not applicable	not applicable	not available	not available	79	not applicable	covid-19	no depletion	79	run 79	proteomic profiling by mass spectrometry	15001336700.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/15001336700.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
PXD029437-Sample-80	Homo sapiens	blood plasma	not applicable	not applicable	not available	not available	80	not applicable	covid-19	no depletion	80	run 80	proteomic profiling by mass spectrometry	15001336727.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/15001336727.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
PXD029437-Sample-81	Homo sapiens	blood plasma	not applicable	not applicable	not available	not available	81	not applicable	covid-19	no depletion	81	run 81	proteomic profiling by mass spectrometry	15001336731.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/15001336731.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
PXD029437-Sample-82	Homo sapiens	blood plasma	not applicable	not applicable	not available	not available	82	not applicable	covid-19	no depletion	82	run 82	proteomic profiling by mass spectrometry	15001336756.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/15001336756.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
PXD029437-Sample-83	Homo sapiens	blood plasma	not applicable	not applicable	not available	not available	83	not applicable	covid-19	no depletion	83	run 83	proteomic profiling by mass spectrometry	15001336760.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/15001336760.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
PXD029437-Sample-84	Homo sapiens	blood plasma	not applicable	not applicable	not available	not available	84	not applicable	covid-19	no depletion	84	run 84	proteomic profiling by mass spectrometry	15001336766.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/15001336766.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
PXD029437-Sample-85	Homo sapiens	blood plasma	not applicable	not applicable	not available	not available	85	not applicable	covid-19	no depletion	85	run 85	proteomic profiling by mass spectrometry	15001336792.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/15001336792.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
PXD029437-Sample-86	Homo sapiens	blood plasma	not applicable	not applicable	not available	not available	86	not applicable	covid-19	no depletion	86	run 86	proteomic profiling by mass spectrometry	15001336812.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/15001336812.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
PXD029437-Sample-87	Homo sapiens	blood plasma	not applicable	not applicable	not available	not available	87	not applicable	covid-19	no depletion	87	run 87	proteomic profiling by mass spectrometry	15001336813.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/15001336813.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
PXD029437-Sample-88	Homo sapiens	blood plasma	not applicable	not applicable	not available	not available	88	not applicable	covid-19	no depletion	88	run 88	proteomic profiling by mass spectrometry	15001336838.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/15001336838.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
PXD029437-Sample-89	Homo sapiens	blood plasma	not applicable	not applicable	not available	not available	89	not applicable	covid-19	no depletion	89	run 89	proteomic profiling by mass spectrometry	15001336925.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/15001336925.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
PXD029437-Sample-90	Homo sapiens	blood plasma	not applicable	not applicable	not available	not available	90	not applicable	covid-19	no depletion	90	run 90	proteomic profiling by mass spectrometry	15001336942.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/15001336942.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
PXD029437-Sample-91	Homo sapiens	blood plasma	not applicable	not applicable	not available	not available	91	not applicable	covid-19	no depletion	91	run 91	proteomic profiling by mass spectrometry	15001336945.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/15001336945.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
PXD029437-Sample-92	Homo sapiens	blood plasma	not applicable	not applicable	not available	not available	92	not applicable	covid-19	no depletion	92	run 92	proteomic profiling by mass spectrometry	15001336951.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/15001336951.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
PXD029437-Sample-93	Homo sapiens	blood plasma	not applicable	not applicable	not available	not available	93	not applicable	covid-19	no depletion	93	run 93	proteomic profiling by mass spectrometry	15001336993.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/15001336993.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
PXD029437-Sample-94	Homo sapiens	blood plasma	not applicable	not applicable	not available	not available	94	not applicable	covid-19	no depletion	94	run 94	proteomic profiling by mass spectrometry	15001337040.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/15001337040.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
PXD029437-Sample-95	Homo sapiens	blood plasma	not applicable	not applicable	not available	not available	95	not applicable	covid-19	no depletion	95	run 95	proteomic profiling by mass spectrometry	15001337083.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/15001337083.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
PXD029437-Sample-96	Homo sapiens	blood plasma	not applicable	not applicable	not available	not available	96	not applicable	covid-19	no depletion	96	run 96	proteomic profiling by mass spectrometry	15001337114.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/15001337114.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
PXD029437-Sample-97	Homo sapiens	blood plasma	not applicable	not applicable	not available	not available	97	not applicable	covid-19	no depletion	97	run 97	proteomic profiling by mass spectrometry	15001337115.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/15001337115.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
PXD029437-Sample-98	Homo sapiens	blood plasma	not applicable	not applicable	not available	not available	98	not applicable	covid-19	no depletion	98	run 98	proteomic profiling by mass spectrometry	15001337117.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/15001337117.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
PXD029437-Sample-99	Homo sapiens	blood plasma	not applicable	not applicable	not available	not available	99	not applicable	covid-19	no depletion	99	run 99	proteomic profiling by mass spectrometry	15001337142.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/15001337142.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
PXD029437-Sample-100	Homo sapiens	blood plasma	not applicable	not applicable	not available	not available	100	not applicable	covid-19	no depletion	100	run 100	proteomic profiling by mass spectrometry	15001337187.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/15001337187.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
PXD029437-Sample-101	Homo sapiens	blood plasma	not applicable	not applicable	not available	male	101	not applicable	normal	no depletion	1	run 101	proteomic profiling by mass spectrometry	control_129.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/control_129.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
PXD029437-Sample-102	Homo sapiens	blood plasma	not applicable	not applicable	not available	male	102	not applicable	normal	no depletion	2	run 102	proteomic profiling by mass spectrometry	control_130.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/control_130.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
PXD029437-Sample-103	Homo sapiens	blood plasma	not applicable	not applicable	not available	male	103	not applicable	normal	no depletion	3	run 103	proteomic profiling by mass spectrometry	control_131.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/control_131.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
PXD029437-Sample-104	Homo sapiens	blood plasma	not applicable	not applicable	not available	male	104	not applicable	normal	no depletion	4	run 104	proteomic profiling by mass spectrometry	control_132.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/control_132.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
PXD029437-Sample-105	Homo sapiens	blood plasma	not applicable	not applicable	not available	male	105	not applicable	normal	no depletion	5	run 105	proteomic profiling by mass spectrometry	control_133.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/control_133.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
PXD029437-Sample-106	Homo sapiens	blood plasma	not applicable	not applicable	not available	male	106	not applicable	normal	no depletion	6	run 106	proteomic profiling by mass spectrometry	control_134.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/control_134.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
PXD029437-Sample-107	Homo sapiens	blood plasma	not applicable	not applicable	not available	male	107	not applicable	normal	no depletion	7	run 107	proteomic profiling by mass spectrometry	control_135.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/control_135.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
PXD029437-Sample-108	Homo sapiens	blood plasma	not applicable	not applicable	not available	male	108	not applicable	normal	no depletion	8	run 108	proteomic profiling by mass spectrometry	control_136.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/control_136.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
PXD029437-Sample-109	Homo sapiens	blood plasma	not applicable	not applicable	not available	male	109	not applicable	normal	no depletion	9	run 109	proteomic profiling by mass spectrometry	control_137.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/control_137.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
PXD029437-Sample-110	Homo sapiens	blood plasma	not applicable	not applicable	not available	male	110	not applicable	normal	no depletion	10	run 110	proteomic profiling by mass spectrometry	control_138.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/control_138.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
PXD029437-Sample-111	Homo sapiens	blood plasma	not applicable	not applicable	not available	male	111	not applicable	normal	no depletion	11	run 111	proteomic profiling by mass spectrometry	control_139.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/control_139.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
PXD029437-Sample-112	Homo sapiens	blood plasma	not applicable	not applicable	not available	male	112	not applicable	normal	no depletion	12	run 112	proteomic profiling by mass spectrometry	control_140.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/control_140.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
PXD029437-Sample-113	Homo sapiens	blood plasma	not applicable	not applicable	not available	male	113	not applicable	normal	no depletion	13	run 113	proteomic profiling by mass spectrometry	control_141.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/control_141.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
PXD029437-Sample-114	Homo sapiens	blood plasma	not applicable	not applicable	not available	male	114	not applicable	normal	no depletion	14	run 114	proteomic profiling by mass spectrometry	control_142.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/control_142.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
PXD029437-Sample-115	Homo sapiens	blood plasma	not applicable	not applicable	not available	male	115	not applicable	normal	no depletion	15	run 115	proteomic profiling by mass spectrometry	control_143.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/control_143.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
PXD029437-Sample-116	Homo sapiens	blood plasma	not applicable	not applicable	not available	male	116	not applicable	normal	no depletion	16	run 116	proteomic profiling by mass spectrometry	control_144.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/control_144.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
PXD029437-Sample-117	Homo sapiens	blood plasma	not applicable	not applicable	not available	male	117	not applicable	normal	no depletion	17	run 117	proteomic profiling by mass spectrometry	control_145.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/control_145.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
PXD029437-Sample-118	Homo sapiens	blood plasma	not applicable	not applicable	not available	male	118	not applicable	normal	no depletion	18	run 118	proteomic profiling by mass spectrometry	control_146.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/control_146.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
PXD029437-Sample-119	Homo sapiens	blood plasma	not applicable	not applicable	not available	male	119	not applicable	normal	no depletion	19	run 119	proteomic profiling by mass spectrometry	control_147.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/control_147.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
PXD029437-Sample-120	Homo sapiens	blood plasma	not applicable	not applicable	not available	male	120	not applicable	normal	no depletion	20	run 120	proteomic profiling by mass spectrometry	control_148.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/control_148.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
PXD029437-Sample-121	Homo sapiens	blood plasma	not applicable	not applicable	not available	male	121	not applicable	normal	no depletion	21	run 121	proteomic profiling by mass spectrometry	control_149.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/control_149.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
PXD029437-Sample-122	Homo sapiens	blood plasma	not applicable	not applicable	not available	male	122	not applicable	normal	no depletion	22	run 122	proteomic profiling by mass spectrometry	control_150.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/control_150.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
PXD029437-Sample-123	Homo sapiens	blood plasma	not applicable	not applicable	not available	male	123	not applicable	normal	no depletion	23	run 123	proteomic profiling by mass spectrometry	control_151.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/control_151.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
PXD029437-Sample-124	Homo sapiens	blood plasma	not applicable	not applicable	not available	male	124	not applicable	normal	no depletion	24	run 124	proteomic profiling by mass spectrometry	control_152.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/control_152.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
PXD029437-Sample-125	Homo sapiens	blood plasma	not applicable	not applicable	not available	male	125	not applicable	normal	no depletion	25	run 125	proteomic profiling by mass spectrometry	control_153.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/control_153.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
PXD029437-Sample-126	Homo sapiens	blood plasma	not applicable	not applicable	not available	male	126	not applicable	normal	no depletion	26	run 126	proteomic profiling by mass spectrometry	control_154.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/control_154.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
PXD029437-Sample-127	Homo sapiens	blood plasma	not applicable	not applicable	not available	male	127	not applicable	normal	no depletion	27	run 127	proteomic profiling by mass spectrometry	control_155.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/control_155.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
PXD029437-Sample-128	Homo sapiens	blood plasma	not applicable	not applicable	not available	male	128	not applicable	normal	no depletion	28	run 128	proteomic profiling by mass spectrometry	control_156.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/control_156.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
PXD029437-Sample-129	Homo sapiens	blood plasma	not applicable	not applicable	not available	male	129	not applicable	normal	no depletion	29	run 129	proteomic profiling by mass spectrometry	control_157.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/control_157.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
PXD029437-Sample-130	Homo sapiens	blood plasma	not applicable	not applicable	not available	male	130	not applicable	normal	no depletion	30	run 130	proteomic profiling by mass spectrometry	control_158.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD029437/control_158.raw	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1002416;NT=Orbitrap Fusion	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	10 ppm	0.01 Da	blood plasma
